An Open-Label, Rater-Blinded, Flexible-Dose, 8-Week Trial of Escitalopram in Patients With Major Depressive Disorder With Atypical Features

Objectives: Although selective serotonin reuptake inhibitors (SSRIs) have become the standard of care for the treatment of major depressive disorder (MDD), limited data exist to support their use in MDD with atypical features. The current study investigates the efficacy of the SSRI escitalopram in a...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Pae, Chi-Un, Masand, Prakash S., Peindl, Kathleen, Mannelli, Paolo, Han, Changsu, Marks, David M., Patkar, Ashwin A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Physicians Postgraduate Press, Inc. 2008
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2446493/
https://ncbi.nlm.nih.gov/pubmed/18615172
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg